Skip to main content
On Hierarchical Composite Endpoints in Pediatric Cancer Supportive Care: Illustrative Examples From Two Multi-Center Phase-III Randomized Clinical Trials.
Factors Impacting Overall Survival Post-Relapse in High-Risk Neuroblastoma: Children's Oncology Group Outcomes From 2000 to 2019.
Consensus Standards and Recommendations for Developmental and Cognitive Surveillance, Screening, and Evaluation in Sickle Cell Disease: Executive Summary From the National Alliance of Sickle Cell Centers Neurocognitive Workgroup.
Clinical and Biological Features of Response in Resistant Neuroblastoma to 131I-Metaiodobenzylguanidine Radiotherapy in the Anti-GD2 Immunotherapy Era.
Protecting Children This World Health Day: The Case for Early Childhood Cancer Detection Through Primary Health Care Strengthening in Vietnam.
Clinical Course and Impact of Breaks in Therapy for Children With Relapsed/Refractory Solid Tumors.
Efficacy and Tolerability of Topotecan/Cyclophosphamide/Dinutuximab in Relapsed and Refractory High-Risk Neuroblastoma: A Multi-Institutional Retrospective Study.
The Price of Survival: Global Inequities in Anti-GD2 Immunotherapy for Neuroblastoma.
Hospital-Based Careers in Pediatric Hematology-Oncology: The State of the Field and Future Needs.
Relation of Adverse Childhood Experiences to Clinical and Patient-Reported Outcomes for Adults With Sickle Cell Disease: A Registry Study.